New supplement aims to prevent muscle loss during dieting
NCT ID NCT07447843
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a nutritional supplement called Redefine in 80 overweight adults who are already taking a weight-loss medication (semaglutide) and following a low-calorie diet. The goal is to see if Redefine is safe and helps preserve muscle mass while losing fat. Participants take the supplement or a placebo for 90 days, and body composition is measured with a DEXA scan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Breakthrough Medical
Lehi, Utah, 84048, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fiber gummies: a tasty new weapon against obesity?
- Can a diabetes drug improve joint replacement outcomes?
- Can a new pill help older adults lose weight without losing strength?
- Can one avocado a day sharpen the aging brain?
- Can a strict diet put type 2 diabetes into remission?
- Can Weight-Loss surgery alter how medications work?